The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar down in Taipei trading
08/14/2026 12:08 PM - Society
Taiwan headline news
08/14/2026 10:20 AM - Business
Taiwan shares open higher
08/14/2026 09:07 AM - Politics
- Society
Ex-Nanya engineer indicted for illegally obtaining confidential data
08/13/2026 08:37 PM